During the past decade, Department of Hematology, Aalborg University Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Hematology, Aalborg University Hospital" #1 sponsor was "Henrik Gregersen" with 3 trials, followed by "Nordic Myeloma Study Group" with 3 trials sponsored, "Aalborg University Hospital" with 2 trials sponsored, "CTI BioPharma" with 1 trials sponsored and "Nordic Lymphoma Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Hematology, Aalborg University Hospital" #1 collaborator was "Danish Myeloma Study Group" with 2 trials as a collaborator, "Aalborg University" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Nordic Cancer Union" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Department of Hematology, Aalborg University Hospital" are "Multiple Myeloma" (6 trials), "Chemotherapy-induced Peripheral Neuropathy" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "DLBCL Transformed From Indolent Lymphoma" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Department of Hematology, Aalborg University Hospital" in a lesser frequency.

Most popular intervention types in "Department of Hematology, Aalborg University Hospital" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Clarithromycin" (2 trials), "Azacitidine" (1 trials), "Bortezomib" (1 trials), "Dexamethasone" (1 trials) and "Erythropoetin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Hematology, Aalborg University Hospital" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Department of Hematology, Aalborg University Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Hematology, Aalborg University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Hematology, Aalborg University Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".